<DOC>
	<DOCNO>NCT00635349</DOCNO>
	<brief_summary>The purpose study compare effectiveness tramadol hydrochloride 37.5 milligram ( mg ) plus acetaminophen 325 mg maintenance non-steroidal anti-inflammatory drug ( NSAIDs ) maintenance participant knee osteoarthritis ( progressive degenerative joint disease , joint become painful stiff ) whose pain relieve add-on treatment tramadol hydrochloride NSAIDs .</brief_summary>
	<brief_title>A Comparative Study Tramadol Hydrochloride Plus Acetaminophen Tablets Maintenance Versus Non-Steroidal Anti-Inflammatory Drugs ( NSAIDs ) Maintenance Participants With Knee Osteoarthritis</brief_title>
	<detailed_description>This multicenter ( one hospital medical school team work medical research study ) , randomize ( study drug assign chance ) , open-label ( people know identity intervention ) , comparative study compare efficacy tramadol hydrochloride plus acetaminophen maintenance NSAIDs maintenance participant whose pain relieve add-on treatment tramadol 37.5 milligram ( mg ) plus acetaminophen 325 mg NSAIDs . All participant receive tramadol hydrochloride 37.5 mg plus acetaminophen 325 mg , 1 3 tablet per day along NSAIDs ( meloxicam [ 7.5 mg 15 mg daily ] aceclofenac [ 100 mg twice daily ] ) Day 1 Day 28 , participant randomly assign 2 treatment group Day 29 numerical rating scale score less equal 4 . Tramadol plus acetaminophen group receive 1 2 tablet contain tramadol 37.5 mg plus acetaminophen 325 mg 4 time daily ( maximum daily dose 8 tablet ) Day 29 Day 85 NSAIDs group receive either meloxicam 7.5 mg 15 mg per day aceclofenac 100 mg twice day Day 29 Day 85 . The efficacy evaluate Day 1 , Day 29 , Day 57 Day 85 . The primary efficacy end point assess change Western Ontario McMaster Universities Osteoarthritis Index ( WOMAC ) total score Day 29 Day 85 . Participant 's safety monitor throughout study .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Aceclofenac</mesh_term>
	<mesh_term>Diclofenac</mesh_term>
	<mesh_term>Meloxicam</mesh_term>
	<mesh_term>Anti-Inflammatory Agents , Non-Steroidal</mesh_term>
	<mesh_term>Tramadol</mesh_term>
	<mesh_term>Acetaminophen</mesh_term>
	<mesh_term>Anti-Inflammatory Agents</mesh_term>
	<criteria>Participants suffer knee osteoarthritis least one year meet criterion American College Rheumatology Participants take stable dose meloxicam 7.5 milligram ( mg ) 15 mg daily aceclofenac 100 mg twice day least four week Participants whose mean pain intensity 5 high numeric rating scale ( NRS ) last 48 hour Participants whose general health condition favorable , accord criterion : Medical medication history , Physical examination study medication administration , Vital sign : Blood pressure , pulse , Clinical laboratory test : Serum glutamic oxaloacetic transaminase ( SGOT ) /serum glutamic pyruvate transaminase ( SGPT ) lessthan equal ( = &lt; ) 2 X normal range , Renal function : Creatinine le ( &lt; ) 2.0 milligram per deciliter ( mg/dl ) Female participant childbearing potential use proper contraceptive method study period ( Urine pregnancy test prior study participation negative ) Participants applicable Kellgren Lawrence grade Participants fail tramadol treatment stop take tramadol due adverse event ( ) Participants applicable one follow condition : Rheumatoid arthritis , Ankylosing spondylitis , Active gout active pseudogout , Diagnosis fibromyalgia ( accord ACR Criteria ) , Anserine bursitis , Major trauma target joint within six month prior study medication administration , Infection target joint within six month prior study medication administration , Apparent avascular necrosis target joint within six month prior study medication administration , Anatomical deformity target joint , may interfere assessment target joint , Surgical procedure associate target joint within one year prior study medication administration , Arthroscopic procedures associate target joint within six month prior study medication administration Participants one follow disease : Significantly unstable disease sleep disorder ( e.g. , sleep apnea narcolepsy ) dementia , Functional damage disease may cause malabsorption , excessive accumulation , metabolism excretion disorder Participants pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>WOMAC</keyword>
	<keyword>Knee osteoarthritis pain</keyword>
	<keyword>Pain intensity</keyword>
	<keyword>Tramadol</keyword>
	<keyword>Acetaminophen</keyword>
	<keyword>Meloxicam</keyword>
	<keyword>Aceclofenac</keyword>
</DOC>